TransMedics (TMDX) EBT Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn | -1,371.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,371.00 |
| Dec 31, 2025 | -5,844.00 |
| Sep 30, 2025 | 1,211.00 |
| Jun 30, 2025 | 1,236.00 |
| Mar 31, 2025 | 579.00 |
| Dec 31, 2024 | -3,232.00 |
| Sep 30, 2024 | 4,444.00 |
| Jun 30, 2024 | 1,250.00 |
| Mar 31, 2024 | 1,911.00 |
| Dec 31, 2023 | 5,943.00 |
| Sep 30, 2023 | -1,170.00 |
| Jun 30, 2023 | 5,418.00 |
| Mar 31, 2023 | 6,016.00 |
| Dec 31, 2022 | -34,893.00 |
| Sep 30, 2022 | 21,045.00 |
| Jun 30, 2022 | 6,697.00 |
| Mar 31, 2022 | 4,572.00 |
| Dec 31, 2021 | 3,254.00 |
| Sep 30, 2021 | -17,555.00 |
| Jun 30, 2021 | 12,738.00 |
| Mar 31, 2021 | -493.00 |
| Dec 31, 2020 | -10,948.00 |
| Sep 30, 2020 | 5,104.00 |
| Jun 30, 2020 | -8,829.00 |
| Mar 31, 2020 | 3,997.00 |
| Dec 28, 2019 | 61,943.00 |
| Sep 28, 2019 | 1,141.00 |
| Jun 29, 2019 | 4,740.00 |
| Mar 30, 2019 | 4,704.00 |